Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5813 posts found.

CHMP begins rolling review of COVID oral antiviral

October 26, 2021 Manufacturing and Production

The EMA’s human medicine’s committee (CHMP) has initiated a rolling review of the investigational antiviral drug molnupiravir for the treatment …
News

Hospitals and pharmacies facing medicine shortages, says The London Economic

October 26, 2021 Manufacturing and Production

As the NHS faces soaring waiting lists and prepares for a winter surge in COVID cases, they must also gear …
News

MHRA licenses uterine fibroid treatment for women in Great Britain

October 26, 2021 Manufacturing and Production

The MHRA has granted a licence for Ryeqo (a relugolix combination therapy), for the treatment of moderate to severe symptoms …
News

Hyloris announces approval of new drug for pain management

October 19, 2021 Manufacturing and Production

Specialist biopharma company Hyloris has announced the further extension of the European footprint of Maxigesic® IV, which is a novel …
News

National Institutes of Health to evaluate Enesi Pharma’s Implavax®-enabled flu vaccines

October 19, 2021 Manufacturing and Production

Enesi Pharma, a pioneering biotechnology company, has entered an agreement with the US National Insitutes of Health’s (NIH) National Institute …
News

Lipocine and Antares Pharma enter agreement to commercialise TLANDO®

October 19, 2021 Manufacturing and Production

Clinical-stage biopharmaceutical company, Lipocine Inc, has announced that it has entered an exclusive licensing agreement with Antares Pharma Inc to …
News

Global Heart Hub and Novartis form partnership to combat ASCVD

October 19, 2021 Manufacturing and Production

Global Heart Hub and Novartis have announced the launch of a joint programme to bring together a worldwide network of …
News

Symbiosis Pharma to manufacture Modus’ sepsis treatment

October 12, 2021 Manufacturing and Production

Modus Therapeutics, a company developing pharmaceutical therapies for diseases with high unmet medical need, has announced that Symbiosis Pharmaceutical Services …
News

Investment into mid-stage tech companies reaches new heights

October 12, 2021 Manufacturing and Production

31 companies have been accepted into Tech Nation’s Upscale growth programme for fast growing, mid-stage (Series A) scaling tech companies. …
News
landing-hero-images1

SMC announces first long-acting injectable HIV treatment

October 12, 2021 Manufacturing and Production

The Scottish Medicines Consortium (SMC) has approved the first long-acting injectable regimen for people living with HIV in Scotland, manufactured …
News

AstraZeneca’s antibody cocktail cuts risk of severe COVID in half, study finds

October 12, 2021 Manufacturing and Production

AstraZeneca’s antibody cocktail against COVID-19, which has proven to work as a preventative shot in the non-infected, has been successful …
News

UK government COVID response “one of UK’s worst ever public health failures”, inquiry finds

October 12, 2021 Manufacturing and Production, Medical Communications

A 150-page report published on Tuesday by the House of Commons, Science and Technology Committee, and Health and Social Care …
News

Transgene and BioInvent to present oncolytic virus data at SITC 2021

October 5, 2021 Manufacturing and Production

Biotech companies Transgene and BioInvent International AB (BioInvent), have announced that they will present preclinical data on their novel dual …
News
6206572255_438e12011d_c

AstraZeneca requests emergency authorisation for COVID-19 drug

October 5, 2021 Manufacturing and Production

AstraZeneca has submitted an FDA request for Emergency Use Authorisation (EUA) for AZD7442, a long-acting antibody combination (LAAB) for the …
News

Kintor begins Phase III trial of proxalutamide for COVID patients in US

October 5, 2021 Manufacturing and Production

Chinese clinical-stage drug developer, Kintor Pharmaceutical Ltd, has announced the initiation of the Phase III clinical trial of proxalutamide for …
News

Latest content

Eisai and Biogen’s Leqembi launched for Alzheimer’s treatment in China

June 28, 2024

AbbVie’s Tepkinly gains positive CHMP opinion for follicular lymphoma treatment

June 28, 2024

IDEAYA Biosciences announces first-patient-in for phase 1 clinical trial evaluating IDE397 and Trodelvy combination in MTAP-deletion bladder cancer

June 27, 2024

Immunotherapy created at Roswell Park Comprehensive Cancer Center given expanded ODD by FDA

June 27, 2024

Abcuro completes enrolment for phase 2/3 IBM treatment trial

June 26, 2024